The 2023 mouse study implanted cancer cells and administered BPC-157
Future BBB imaging studies may aid our understanding of comorbidities associated with TBI such as AD, post-traumatic epilepsy, and chronic traumatic encephalopathy (Figure 2E summarizes the main processes driving BBB disruption, the key factors involved and the role of BBB imaging in TBI
SFN acts as a cytoprotective factor in different types of cellular stress by triggering the oxidative stress response (OSR) and decreasing inflammation
Pigmentation is hereditary and thus cannot be treated with mere home remedies
What to expect after a vitamin B12 injection Response to vitamin B12 replacement varies and depends on the cause of the deficiency
(2022) demonstrated Cerebrolysin's effects on Alzheimer's disease biomarkers in a randomized controlled trial, providing objective biological evidence for its neurotrophic activity (PMID: 36155516) Regulatory Validation: Approved for clinical use in over 40 countries for indications including stroke, traumatic brain injury, and dementia (though not FDA-approved in the United States) Dihexa: Preclinical Only, with Integrity Concerns Dihexa's evidence base is entirely preclinical and has faced significant scientific integrity challenges: Foundational Research: Wright et al